# Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy

> **NCT01956799** · — · COMPLETED · sponsor: **Fondazione Italiana Sindromi Mielodisplastiche-ETS** · enrollment: 100 (estimated)

## Conditions studied

- Myelodysplasia
- Myelofibrosis
- Aplastic Anemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01956799
- **Lead sponsor:** Fondazione Italiana Sindromi Mielodisplastiche-ETS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2018-07
- **Final completion:** 2019-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01956799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01956799, "Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01956799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*